Follow-up of Study AN004T to Assess the Persistence of AllerT Efficacy During the 2nd to 4th Season After Treatment

CompletedOBSERVATIONAL
Enrollment

196

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Birch Pollen Allergy
Trial Locations (22)

1003

Center of examination and treatment of allergic diseases, Riga

1005

Centre Hospitalier Universitaire Vaudois, Lausanne

2900

Allergiklinikken, Hellerup

4601

Viktorija Vevere private practice of Allergology, Rēzekne

5000

Klinisk Institute, Odense

8000

Lungemedicinsk Forskningsafdeling, Aarhus

10200

Antakalnio affiliation of the Vilnius City Allergy Center, Vilnius

20095

Alergotest, Lublin

22185

University hospital Skane, Lund

33100

Alergo-Med, Tarnów

41800

NZOZ Przychodnia Lekarska Hipokrates, Zabrze

50009

Kaunas Clinics University Hospital, Kaunas

54203

Aler-med, Wroclaw

67000

Hopitaux Universitaires de Strasbourg, Strasbourg

70185

Orebro University Hospital, Örebro

72189

Lungavdelningen, Vastmanlands, Västerås

90153

SPZOZ Uniwersytecki Szpital Kliniczny - Allergology, Lodz

90553

Alergologii Centrum, Lodz

08431

Allergy Clinic JSC Perspektyvos, Vilnius

08661

Vilnius University Hospital, Vilnius

01157

Centrum Alergologii IRMED, Warsaw

50-368

Silesian Piasts University of Medicine in Wrocław, Wroclaw

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Anergis

INDUSTRY

NCT02143583 - Follow-up of Study AN004T to Assess the Persistence of AllerT Efficacy During the 2nd to 4th Season After Treatment | Biotech Hunter | Biotech Hunter